article thumbnail

Innovative Cannabis Brand Escape Artists Expands Into Michigan, Debuts Pharmaceutical-Grade Topicals

Medical Marijuana Program Connection

–(BUSINESS WIRE)–Colorado-based cannabis brand Escape Artists, a top-selling maker of infused topicals for pain relief and recovery, today announced. KALKASKA, Mich.–(BUSINESS Read More

Topical 52
article thumbnail

The Pharmaceutical Industry’s Relationship With Cannabis

Kind Meds (Cannabis Education Blog)

Over the years, it has gone from being commonly used to a controversial topic. At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Cannabis has had a long, changing history in the United States. Its current value sits at over one trillion dollars.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs?

United Patients Group

While there are many different types of cannabis products on the market today– including oils , edibles and topicals–the most common form is dried flower buds (aka bud). The post Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs? Remember, cannabis is not a one size fits all type of medicine.

article thumbnail

Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna’s Evidence-Based Topical Products through Heritage’s Medical Opticann Brands

Cannabis Law Report

Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98
article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S.

Leaf Science

study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. Looking at the topic of medical cannabis, 84% of consumers who participated in the study believed that cannabis has legitimate medical uses.

article thumbnail

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

SOURCE InMed Pharmaceuticals Inc. INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. InMed Pharmaceuticals is exploring the therapeutic potential of CBN in diseases with high unmet medical needs.